J9003Drugs Administered Other than Oral Method

Leuprolide injectable (camcevi etm), 1 mg

Short description: Leupro inj, camcevi etm, 1mg

Effective date: April 1, 2026
Termination date: —

Related codes (J-series)

J0013Esketamine, nasal spray J0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius J0135Adalimumab injection

Frequently asked questions

What is HCPCS code J9003?

J9003 is a HCPCS Level II code for Leuprolide injectable (camcevi etm), 1 mg.

What category is HCPCS code J9003 in?

J9003 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.

When did HCPCS code J9003 become effective?

J9003 has been effective since April 1, 2026, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.